RCEL
Avita Medical Ltd
13.30$
+2.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 15.5% | 12.7% | 13.6% | 13.9% | 16.3% | 12.4% | 15.3% | 18.8% | 18.7% | 18.8% | 18.3% | 18.1% | 18.4% | |
| 84.5% | 87.3% | 86.4% | 86.1% | 83.7% | 87.6% | 84.7% | 81.2% | 81.3% | 81.2% | 81.7% | 81.9% | 81.6% | |
| 32.2% | 47.7% | 46.8% | 32.2% | 27.8% | 26.4% | 33.9% | 27.8% | 22.0% | 32.3% | 29.2% | 23.4% | 26.6% | |
| 44.9% | 54.6% | 80.7% | 49.5% | 49.1% | 38.7% | 34.5% | 36.2% | 42.4% | 40.2% | 31.5% | 27.5% | 34.8% | |
| 152.7% | 173.8% | 241.3% | 188.9% | 154.3% | 141.7% | 148.6% | 141.7% | 135.0% | 140.3% | 127.4% | 113.5% | 128.1% | |
| -68.2% | -86.5% | -155.0% | -102.8% | -70.6% | -54.1% | -63.9% | -60.5% | -53.6% | -59.1% | -45.7% | -31.6% | -46.6% | |
| 0.1% | 7.9% | 12.2% | 8.9% | 7.0% | 7.1% | 6.7% | 6.8% | 7.4% | 7.1% | 7.4% | 6.7% | 7.1% | |
| -63.8% | -49.7% | -167.8% | -101.1% | -83.1% | -62.9% | -74.8% | -53.8% | -77.2% | -66.1% | -55.2% | -35.2% | -56.9% | |
| 0.1% | 0.1% | 0.3% | 0.2% | -0.1% | 0.1% | 0.0% | 0.0% | 0.1% | -0.1% | -0.1% | 0.2% | 0.0% | |
| -63.8% | -49.8% | -168.0% | -101.3% | -82.9% | -63.0% | -74.9% | -53.9% | -77.3% | -66.0% | -55.1% | -35.3% | -57.0% | |
| -62.5% | -40.5% | -153.7% | -90.9% | -74.5% | -53.6% | -65.3% | -44.0% | -66.4% | -55.1% | -44.5% | -22.2% | -45.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.